Metraipolis › archive › dc_7dff0c4e5d49

Improving the bioavailability of nintedanib by formulating inhalable ufasomes as a targeted therapy for non-small cell lung cancer — Europe PMC PMID:41625777

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41625777
DOI: 10.1016/j.ijpx.2025.100482
License (as archived): solo-consultazione
Archived: 2026-11-07T08:02:52.149Z
SHA-256 of the archived text: 26b66cf6d22d81bb1997033ed6c2620a7a1ac2df17d2a61ecdf705f4aa244d42
Stable URL of this page: https://metraipolis.com/documento/dc_7dff0c4e5d49

How to cite

Improving the bioavailability of nintedanib by formulating inhalable ufasomes as a targeted therapy for non-small cell lung cancer — Europe PMC PMID:41625777 — Europe PMC (en), https://europepmc.org/article/MED/41625777 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7dff0c4e5d49 (Metraipolis archive dc_7dff0c4e5d49, sha256 26b66cf6d22d81bb1997033ed6c2620a7a1ac2df17d2a61ecdf705f4aa244d42)

BibTeX

@misc{dc7dff0c4e5d49,
  title = {Improving the bioavailability of nintedanib by formulating inhalable ufasomes as a targeted therapy for non-small cell lung cancer — Europe PMC PMID:41625777},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41625777},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7dff0c4e5d49; sha256 26b66cf6d22d81bb1997033ed6c2620a7a1ac2df17d2a61ecdf705f4aa244d42},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41625777. Agents can read the archived copy with the MCP tool read_document.